{
    "organizations": [],
    "uuid": "6452a6ac1ed970bfeb569598553230a5dbac2481",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-juniper-pharmaceuticals-reports-q1/brief-juniper-pharmaceuticals-reports-q1-earnings-per-share-of-0-06-idUSASC0A1D1",
    "ord_in_thread": 0,
    "title": "BRIEF-Juniper Pharmaceuticals Reports Q1 Earnings Per Share Of $0.06",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Juniper Pharmaceuticals Inc:\n* JUNIPER PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS\n* Q1 REVENUE $15.5 MILLION * JUNIPER PHARMACEUTICALS - “ENGAGEMENT WITH ROTHSCHILD TO PURSUE STRATEGIC ALTERNATIVES IS PROGRESSING” Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T19:13:00.000+03:00",
    "crawled": "2018-05-11T12:52:32.026+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "juniper",
        "pharmaceutical",
        "inc",
        "juniper",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "operating",
        "result",
        "q1",
        "revenue",
        "million",
        "juniper",
        "pharmaceutical",
        "engagement",
        "rothschild",
        "pursue",
        "strategic",
        "alternative",
        "progressing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}